Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 1
2005 1
2006 1
2016 1
2017 2
2018 1
2020 3
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
Stebbing J, Krishnan V, de Bono S, Ottaviani S, Casalini G, Richardson PJ, Monteil V, Lauschke VM, Mirazimi A, Youhanna S, Tan YJ, Baldanti F, Sarasini A, Terres JAR, Nickoloff BJ, Higgs RE, Rocha G, Byers NL, Schlichting DE, Nirula A, Cardoso A, Corbellino M; Sacco Baricitinib Study Group. Stebbing J, et al. Among authors: richardson pj. EMBO Mol Med. 2020 Aug 7;12(8):e12697. doi: 10.15252/emmm.202012697. Epub 2020 Jun 24. EMBO Mol Med. 2020. PMID: 32473600 Free PMC article.
CXCR4 and Glioblastoma.
Richardson PJ. Richardson PJ. Anticancer Agents Med Chem. 2016;16(1):59-74. doi: 10.2174/1871520615666150824153032. Anticancer Agents Med Chem. 2016. PMID: 26299663 Review.
CNS penetration of potential anti-COVID-19 drugs.
Richardson PJ, Ottaviani S, Prelle A, Stebbing J, Casalini G, Corbellino M. Richardson PJ, et al. J Neurol. 2020 Jul;267(7):1880-1882. doi: 10.1007/s00415-020-09866-5. Epub 2020 May 2. J Neurol. 2020. PMID: 32361836 Free PMC article. Review. No abstract available.
Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma.
Carvalho DM, Richardson PJ, Olaciregui N, Stankunaite R, Lavarino C, Molinari V, Corley EA, Smith DP, Ruddle R, Donovan A, Pal A, Raynaud FI, Temelso S, Mackay A, Overington JP, Phelan A, Sheppard D, Mackinnon A, Zebian B, Al-Sarraj S, Merve A, Pryce J, Grill J, Hubank M, Cruz O, Morales La Madrid A, Mueller S, Carcaboso AM, Carceller F, Jones C. Carvalho DM, et al. Among authors: richardson pj. Cancer Discov. 2022 Feb;12(2):416-431. doi: 10.1158/2159-8290.CD-20-1201. Epub 2021 Sep 22. Cancer Discov. 2022. PMID: 34551970 Free PMC article.
Baricitinib for COVID-19: a suitable treatment? - Authors' reply.
Richardson PJ, Corbellino M, Stebbing J. Richardson PJ, et al. Lancet Infect Dis. 2020 Sep;20(9):1013-1014. doi: 10.1016/S1473-3099(20)30270-X. Epub 2020 Apr 3. Lancet Infect Dis. 2020. PMID: 32251639 Free PMC article. No abstract available.
Variation in postacute care utilization after complex surgery.
Balentine CJ, Mason MC, Richardson PJ, Kougias P, Bakaeen F, Naik AD, Berger DH, Anaya DA. Balentine CJ, et al. Among authors: richardson pj. J Surg Res. 2018 Oct;230:61-70. doi: 10.1016/j.jss.2018.04.052. Epub 2018 May 25. J Surg Res. 2018. PMID: 30100041
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models.
Gravina GL, Mancini A, Colapietro A, Vitale F, Vetuschi A, Pompili S, Rossi G, Marampon F, Richardson PJ, Patient L, Patient L, Burbidge S, Festuccia C. Gravina GL, et al. Among authors: richardson pj. Tumour Biol. 2017 Jun;39(6):1010428317695528. doi: 10.1177/1010428317695528. Tumour Biol. 2017. PMID: 28639900 Free article.
19 results